Live from the NIH registry
Studies recruiting near Riverside right now
Top 25 of 936 recruiting studies, sorted by proximity — each links to its official registry page
Effect of Electro-Acupuncture on Blood Pressure
Hypertension
N/A
Interventional 160 participants sought
UCIMedical Center — Orange, California (28.3 mi)
· Sponsor: University of California, Irvine
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Loma Linda University Medical Center — Loma Linda, California (10.8 mi)
· Sponsor: National Cancer Institute (NCI)
Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)
Primary Membranous Nephropathy
Phase 2
Interventional 30 participants sought
Research Site — Loma Linda, California (10.8 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Loma Linda University Medical Center — Loma Linda, California (10.8 mi)
· Sponsor: Medtronic MiniMed, Inc.
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)
Phase 1
Interventional 248 participants sought
University of California Irvine — Orange, California (28.3 mi)
· Sponsor: Nurix Therapeutics, Inc.
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
Phase 2
Interventional 120 participants sought
University of California Irvine — Orange, California (28.3 mi)
· Sponsor: Regeneron Pharmaceuticals
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis
Phase 2
Interventional 168 participants sought
North America Research Institute — San Dimas, California (26.3 mi)
· Sponsor: R1 Therapeutics
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Riverside Community Hospital — Riverside, California (1.1 mi)
· Sponsor: Duke University
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Kaiser Permanente-Riverside — Riverside, California (1.1 mi)
· Sponsor: SWOG Cancer Research Network
Mobile Health Intervention to Improve Adherence to Oral Anticancer Therapy
Cancer, Neoplasms
N/A
Interventional 35 participants sought
UCI Health - Yorba Linda — Yorba Linda, California (24.2 mi)
· Sponsor: University of California, Irvine
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma
Phase 3
Interventional 1,524 participants sought
UC Irvine Health/Chao Family Comprehensive Cancer Center — Orange, California (28.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Gen 2 Battrode Wear Study
Adhesive Wear Time
N/A
Interventional 30 participants sought
Orange County Research Center — Lake Forest, California (26.3 mi)
· Sponsor: Baxter Healthcare Corporation
Evaluating the Impact of Training for IHSS Workers
Home Care for Elderly or Disabled Individuals
N/A
Interventional 2,500 participants sought
San Bernardino County — San Bernardino, California (13.2 mi)
· Sponsor: Abdul Latif Jameel Poverty Action Lab
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Kaiser Permanente-Riverside — Riverside, California (1.1 mi)
· Sponsor: NRG Oncology
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
Infinity Clinical Research — Norco, California (8.8 mi)
· Sponsor: Crystalys Therapeutics
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
University of California, Irvine (UCI) Health - UC Irvine Medical Center — Orange, California (28.3 mi)
· Sponsor: Eli Lilly and Company
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients
Irritability Associated With Autism Spectrum Disorder
Phase 3
Interventional 160 participants sought
Inland Psychiatric Medical Group Inc — Redlands, California (14.6 mi)
· Sponsor: Intra-Cellular Therapies, Inc.
Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
IgA Nephropathy
Phase 4
Interventional 60 participants sought
Loma Linda University — San Bernardino, California (13.2 mi)
· Sponsor: Calliditas Therapeutics AB
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Intracerebral Hemorrhage
Phase 3
Interventional 350 participants sought
Kaiser Permanente Riverside Medical Center — Riverside, California (1.1 mi)
· Sponsor: Joseph Broderick, MD
[18F]PI-2620 Phase 3 Histopathological Study
Alzheimer Disease
Phase 3
Interventional 200 participants sought
Esperanza Clinical — Murrieta, California (28.5 mi)
· Sponsor: Lantheus Biosciences Ltd.
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
IC-MPGN
Phase 3
Interventional 106 participants sought
Univ Cali Irvine ALS Neuromuscular — Orange, California (28.3 mi)
· Sponsor: Novartis Pharmaceuticals
Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 1
Interventional 24 participants sought
Children'S Hospital of Orange County — Orange, California (28.3 mi)
· Sponsor: Incyte Corporation
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
Asthma
Phase 3
Interventional 440 participants sought
Research Site — Riverside, California (1.1 mi)
· Sponsor: AstraZeneca
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer
Phase 3
Interventional 1,000 participants sought
UCLA Hematology/Oncology - Laguna Hills — Laguna Hills, California (29.0 mi)
· Sponsor: Pfizer
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
Pulmonary Invasive Fungal Infections, Pulmonary Invasive Aspergillosis
N/A
Observational 400 participants sought
Children's Hospital of Orange County — Orange, California (28.3 mi)
· Sponsor: Arkansas Children's Hospital Research Institute